Picture of Beleave logo

BLEVF Beleave Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Beleave, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2015
March 31st
2016
March 31st
2017
March 31st
2018
March 31st
2019
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.51-2.99-8.55-12.6-33.8
Depreciation
Non-Cash Items02.216.018.0721.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.1380.4171.28-1.64-0.017
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.372-0.36-1.26-5.88-9.47
Capital Expenditures-0.862-0.039-1-1.68-8.74
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.221
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-0.862-0.039-1-1.68-8.96
Financing Cash Flow Items-0.038-0.003-6.64
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3580.3994.0917.56.97
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.876-01.839.94-11.5